Facebook Pixel Empowering Women in STEM: Viet Nam's Journey Towards Innovation and Equality | BioSpectrum Asia - business - Les denne historien på Magzter.com

Prøve GULL - Gratis

Empowering Women in STEM: Viet Nam's Journey Towards Innovation and Equality

BioSpectrum Asia

|

March 2025

2025 marks the 10th anniversary of the International Day of Women and Girls in Science (IDWGS) (observed on February 11) and the 30th anniversary of the Beijing Declaration and Platform for Action, two significant milestones in the global effort to promote gender equality and women's empowerment. Recognising the importance of gender inclusivity, Viet Nam has taken major policy steps to empower female researchers and entrepreneurs. By investing in education, policy reforms, and celebrating the achievements of women scientists, the country is setting a global example for inclusive development.

- Dang Hoang Giang,

Empowering Women in STEM: Viet Nam's Journey Towards Innovation and Equality

This year marks the 10th anniversary of the International Day of Women in STEM, highlighting a decade of progress in closing gender disparities in science, technology, engineering, and mathematics (STEM). While there have been significant global advancements, women remain under-represented in STEM, particularly in leadership roles and high-tech industries.

Despite making up 49.7 per cent of the global population, according to UNESCO, only 28 per cent of researchers worldwide are women, with even lower numbers in leadership positions and emerging sectors like AI and biotechnology. In Asia, the gender gap is even more pronounced. India, for example, reports that only 14 per cent of STEM academic positions are held by women, according to IWWAGE report

One key challenge is the "leaky pipeline" phenomenon, where women leave STEM careers at higher rates due to cultural biases, workplace inequities, and family responsibilities. This issue is not just about representation but also economic loss. According to the Asian Development Bank, gender gaps in STEM cost the Asia-Pacific region an estimated $42 billion annually, slowing economic growth and innovation. Furthermore, homogeneous teams in fields like biotechnology and pharmaceuticals risk overlooking solutions that address diverse populations, limiting breakthroughs in precision medicine and public health.

According to a McKinsey Global Institute report it is estimated that achieving gender parity in STEM could boost global GDP by $12 trillion by 2030, reinforcing the urgency of inclusive policies to increase women representation in STEM sectors, both in quantity and quality.

FLERE HISTORIER FRA BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

Malaysia, Thailand implement medical device reliance programme after successful pilot

The Medical Device Authority (MDA) of Malaysia and the Thai Food and Drug Administration (Thai FDA) signed a Confidentiality Agreement to deepen regulatory cooperation and officially launched a 3-month pilot of the Medical Device Regulatory Reliance Programme as part of the agreement.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

Strand Life Sciences launches South Asia's first Olink Explore HT Proteomics Service

India-based Strand Life Sciences, a subsidiary of Reliance Industries Limited, has announced the launch of its advanced proteomics capabilities powered by Olink Explore HT, marking a key milestone in expanding largescale multi-omics research in South Asia.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

UK transforms mental healthcare with new strategy

Frontline workers, clinicians and mental health experts are being invited to share their views on how to transform mental healthcare for children and adults in England, as the government launches a call for evidence to shape its once-in-a-generation crossgovernment mental health strategy.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

Australia Budget 2026-27: Investing in Care, Health and Innovation.

The Australian Federal Budget 2026-27, presented by the Albanese Government, places strong emphasis on healthcare, aged care, T disability services, research, innovation and social equality.

time to read

4 mins

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

Gavi proposes new incentives for advancing vaccine manufacturing in Africa

With Gavi's African Vaccine Manufacturing Accelerator (AVMA) expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, Gavi, the Vaccine Alliance has proposed further measures totaling $189 million of additional investment to further aid development of Africa's vaccine manufacturing sector.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

New WHO online course strengthens good practices in clinical trials

High-quality clinical trials are essential for generating reliable evidence to inform health policy, clinical practice and public trust in science.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

World Bank approves $225 M to improve healthcare in Côte d'Ivoire

The World Bank has approved $225 million in financing to help Côte d'Ivoire improve the delivery of quality health, nutrition, and early childhood development services for millions of people, particularly for women, children, and vulnerable households.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

Nona Biosciences appoints Dr Josh Xiao as CSO

Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, has announced the appointment of Dr Josh Xiao as Chief Scientific Officer (CSO). Dr Xiao will be based in both the US and China and report directly to Dr Di Hong, Chief Executive Officer of Nona Biosciences.

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

Korea lays focus on stabilising medical product supply

The Ministry of Health and Welfare (MoHW), South Korea government, recently held its 7th meeting with healthcare and pharmaceutical associations, bringing together the Ministry of Trade, Industry and Resources (MOTIR), and the Ministry of Food and Drug Safety (MFDS).

time to read

1 min

BioSpectrum Asia June 2026

BioSpectrum Asia

BioSpectrum Asia

Formosa Pharma partners with SERI to advance novel ophthalmic formulations for corneal diseases

Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have announced a strategic research collaboration to develop next-generation ophthalmic formulations.

time to read

1 min

BioSpectrum Asia June 2026

Listen

Translate

Share

-
+

Change font size